IL-1 Signal Inhibition In Alcoholic Hepatitis (ISAIAH): a study protocol for a multicentre, randomised, placebo-controlled trial to explore the potential benefits of canakinumab in the treatment of alcoholic hepatitis (2021)

First Author: Vergis N
Attributed to:  MICA: Minimising Mortality from Alcoholic Hepatitis funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1186/s13063-021-05719-2

PubMed Identifier: 34763711

Publication URI: http://europepmc.org/abstract/MED/34763711

Type: Journal Article/Review

Parent Publication: Trials

Issue: 1

ISSN: 1745-6215